Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas J Wareham

Showing results (441-450 of 904) with videos related to

Pageof 91
Sort By:
Nature Communications|July 8, 2021
GIGYF1 loss of function is associated with clonal mosaicism and adverse metabolic healthYajie Zhao, Stasa Stankovic, Mine Koprulu, et al.
The American Journal of Clinical Nutrition|July 4, 2014
Serum carbon and nitrogen stable isotopes as potential biomarkers of dietary intake and their relation with incident type 2 diabetes: the EPIC-Norfolk studyPinal S Patel, Andrew J M Cooper, Tamsin C O'Connell, et al.
The Lancet Regional Health. Western Pacific|April 10, 2025
Associations of reallocating sedentary leisure-time to alternative discretionary movement behaviours with incident cardiometabolic diseases in 0.5 million Chinese adultsPaul J Collings, Mengyao Wang, Harrison Hin Sheung Ho, et al.
Journal of the American College of Cardiology|February 6, 2007
Value of low-density lipoprotein particle number and size as predictors of coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population StudyKarim El Harchaoui, Wim A van der Steeg, Erik S G Stroes, et al.
Thorax|October 15, 2021
Metabolomic differences in lung function metrics: evidence from two cohortsRachel S Kelly, Isobel D Stewart, Haley Bayne, et al.
Annals of Internal Medicine|January 21, 2009
High-density lipoprotein particle size and concentration and coronary riskKarim El Harchaoui, Benoit J Arsenault, Remco Franssen, et al.
Plos One|August 28, 2009
Both paraoxonase-1 genotype and activity do not predict the risk of future coronary artery disease; the EPIC-Norfolk Prospective Population StudyRakesh S Birjmohun, Menno Vergeer, Erik S G Stroes, et al.
Journal of Clinical Lipidology|September 26, 2018
Relationship of lipoprotein-associated apolipoprotein C-III with lipid variables and coronary artery disease risk: The EPIC-Norfolk prospective population studyJulian C van Capelleveen, Sang-Rok Lee, Rutger Verbeek, et al.
Human Molecular Genetics|August 8, 2002
A missense mutation disrupting a dibasic prohormone processing site in pro-opiomelanocortin (POMC) increases susceptibility to early-onset obesity through a novel molecular mechanismBenjamin G Challis, Lynn E Pritchard, John W M Creemers, et al.
Nature Communications|January 19, 2023
Large scale phenotype imputation and in vivo functional validation implicate ADAMTS14 as an adiposity geneKatherine A Kentistou, Jian'an Luan, Laura B L Wittemans, et al.
Pageof 91

Showing results (441-450 of 904) with videos related to

Sort By:
Pageof 91
Nature Communications|July 8, 2021
GIGYF1 loss of function is associated with clonal mosaicism and adverse metabolic healthYajie Zhao, Stasa Stankovic, Mine Koprulu, et al.
The American Journal of Clinical Nutrition|July 4, 2014
Serum carbon and nitrogen stable isotopes as potential biomarkers of dietary intake and their relation with incident type 2 diabetes: the EPIC-Norfolk studyPinal S Patel, Andrew J M Cooper, Tamsin C O'Connell, et al.
The Lancet Regional Health. Western Pacific|April 10, 2025
Associations of reallocating sedentary leisure-time to alternative discretionary movement behaviours with incident cardiometabolic diseases in 0.5 million Chinese adultsPaul J Collings, Mengyao Wang, Harrison Hin Sheung Ho, et al.
Journal of the American College of Cardiology|February 6, 2007
Value of low-density lipoprotein particle number and size as predictors of coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population StudyKarim El Harchaoui, Wim A van der Steeg, Erik S G Stroes, et al.
Thorax|October 15, 2021
Metabolomic differences in lung function metrics: evidence from two cohortsRachel S Kelly, Isobel D Stewart, Haley Bayne, et al.
Annals of Internal Medicine|January 21, 2009
High-density lipoprotein particle size and concentration and coronary riskKarim El Harchaoui, Benoit J Arsenault, Remco Franssen, et al.
Plos One|August 28, 2009
Both paraoxonase-1 genotype and activity do not predict the risk of future coronary artery disease; the EPIC-Norfolk Prospective Population StudyRakesh S Birjmohun, Menno Vergeer, Erik S G Stroes, et al.
Journal of Clinical Lipidology|September 26, 2018
Relationship of lipoprotein-associated apolipoprotein C-III with lipid variables and coronary artery disease risk: The EPIC-Norfolk prospective population studyJulian C van Capelleveen, Sang-Rok Lee, Rutger Verbeek, et al.
Human Molecular Genetics|August 8, 2002
A missense mutation disrupting a dibasic prohormone processing site in pro-opiomelanocortin (POMC) increases susceptibility to early-onset obesity through a novel molecular mechanismBenjamin G Challis, Lynn E Pritchard, John W M Creemers, et al.
Nature Communications|January 19, 2023
Large scale phenotype imputation and in vivo functional validation implicate ADAMTS14 as an adiposity geneKatherine A Kentistou, Jian'an Luan, Laura B L Wittemans, et al.
Pageof 91